address1,address2,city,zip,country,phone,fax,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,auditRisk,boardRisk,compensationRisk,shareHolderRightsRisk,overallRisk,governanceEpochDate,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,exDividendDate,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,marketState,regularMarketChangePercent,regularMarketPrice,hasPrePostMarketData,firstTradeDateMilliseconds,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,earningsCallTimestampStart,earningsCallTimestampEnd,isEarningsDateEstimate,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,shortName,longName,cryptoTradeable,corporateActions,regularMarketTime,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,trailingPegRatio
Gustavslundsvägen 42,5th floor,Bromma,167 51,Sweden,46 8 52 23 07 00,46 87 35 20 29,https://www.mobergpharma.se,Drug Manufacturers - Specialty & Generic,drug-manufacturers-specialty-generic,Drug Manufacturers - Specialty & Generic,Healthcare,healthcare,Healthcare,"Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is based in Bromma, Sweden.",9,"[{'maxAge': 1, 'name': 'Dr. Jonas  Ekblom Ph.D.', 'age': 59, 'title': 'Executive Chairman', 'yearBorn': 1965, 'fiscalYear': 2024, 'totalPay': 111000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Anna  Ljung BA, M.Sc.', 'age': 44, 'title': 'Chief Executive Officer', 'yearBorn': 1980, 'fiscalYear': 2024, 'totalPay': 3100000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Marie  Moberg', 'title': 'Co-Founder', 'fiscalYear': 2024, 'totalPay': 193701, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Mark  Beveridge', 'age': 46, 'title': 'Vice President of Finance', 'yearBorn': 1978, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Christina  Erixon', 'age': 54, 'title': 'Head of Pharmaceutical Development & Operations', 'yearBorn': 1970, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Amir  Tavakkol Ph.D.', 'age': 69, 'title': 'Chief Scientific Officer', 'yearBorn': 1955, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Gunilla  Wengström', 'title': 'Senior Director of Sales & Marketing', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}]",8,8,6,4,8,1748736000,1735603200,[],86400,2,8.795,8.795,8.74,8.85,8.795,8.795,8.74,8.85,1572825600,0.0,0.777,-44.175,52903,52903,141737,339262,339262,8.835,8.85,0,0,418083680,6.335,39.78,32.510395,8.519,10.100875,0.0,0.0,SEK,False,160700192,0.0,41523446,47000600,0.17438999,0.10213,0,14.68,0.60183924,1735603200,1767139200,1743379200,-251384000,-6.54,-0.2,1:10,1684886400,12.496,-0.501,-0.7649653,0.12153554,EQUITY,8.835,11.0,11.0,11.0,11.0,none,1,268895008,5.759,-320536992,3752000,18.064,18.452,12860000,0.547,0.302,-0.3007,-0.38964,8388000,22896250,-21398000,3.718,0.65226,0.0,-1.06823,SEK,MOB.ST,en-US,US,Equity,Delayed Quote,True,HIGH,PREPRE,0.4548034,8.835,False,1306393200000,0.03999996,8.74 - 8.85,Stockholm,141737,2.5,0.394633,6.335 - 39.78,-30.945,-0.7779035,-76.49653,1754978400,1754978400,1754978400,1739282400,1739282400,False,-6.54,-0.2,-0.3,-29.449999,0.31599998,0.037093554,-1.2658749,-0.1253233,15,0,Moberg Pharma AB,Moberg Pharma AB (publ),False,[],1752074997,STO,finmb_35248832,Europe/Stockholm,CEST,7200000,se_market,False,
